Quanex Building Products Corporation — Q1 FY2022 Form 10-Q
Business context and reporting period. Quanex supplies components to building-products OEMs, including window, door, and cabinet manufacturers. This unaudited quarter covers the three months ended January 31, 2022; comparisons are with the three months ended January 31, 2021. Amounts below are in U.S. dollars.
Key financial results
| Metric | Q1 FY2022 | Q1 FY2021 | Change |
|---|---|---|---|
| Net sales | $267.0 million | $230.1 million | +16% |
| Operating income | $14.1 million | $11.8 million | +19% |
| Net income | $11.2 million | $7.9 million | +42% |
| Diluted EPS | $0.34 | $0.24 | +$0.10 |
| Cash used for operating activities | $21.7 million | $3.4 million | $18.3 million more used |
| Capital expenditures | $7.4 million | $5.2 million | +$2.2 million |
| Cash dividends per share | $0.08 | $0.08 | No change |
Margins. Operating margin was approximately 5.3%, versus 5.1% a year earlier. Cost of sales excluding depreciation and amortization rose faster than sales, to $211.8 million from $176.4 million; on that basis, gross margin declined to approximately 20.7% from 23.4%. Net margin was approximately 4.2%, versus 3.4%.
Cash, debt, and liquidity. Cash was $31.7 million at January 31, 2022, down from $40.1 million at October 31, 2021. Total debt was $77.5 million, compared with $52.9 million at fiscal year-end; this included $63.0 million drawn on the revolving facility and $15.0 million of finance leases and other debt. The company reported $257.5 million available under its $325.0 million credit facility and was in compliance with its covenants. Current assets were $260.1 million and current liabilities $131.6 million. Operating cash use reflected working-capital needs, especially inventory growth and incentive payouts; financing included $24.8 million of net debt borrowings. Cash used for operations and capital expenditures together was approximately $29.0 million.
Changes and segment performance
- Sales growth drivers: Management attributed growth to pricing, raw-material surcharges, and higher volumes overall. NA Fenestration sales rose 14%; EU Fenestration sales rose 20%; and NA Cabinet Components sales rose 16%.
- Profitability varied by segment: NA Fenestration operating income increased to $12.2 million from $11.2 million, although margin declined to about 8% from 9%. EU Fenestration operating income decreased to $7.8 million from $8.2 million, with margin falling to about 13% from 17%. NA Cabinet Components reported an operating loss of $1.5 million, versus a $0.0 million loss in the prior-year quarter, as costs rose and volumes declined.
- Corporate costs: Unallocated Corporate & Other operating loss improved to $4.4 million from $7.5 million, partly due to lower stock-based compensation expense and the absence of a prior-year plant-sale loss.
- Tax and interest: Interest expense declined to $0.5 million from $0.8 million. Reported effective tax rates were 17.7% and 30.4%, respectively; the filing cites equity-award-related tax benefits as a driver of the year-over-year tax-expense decrease.
Outlook, risks, and unusual items
- Outlook: The filing provides no specific company revenue or earnings guidance. It cites third-party forecasts of 1.6 million U.S. housing starts for calendar 2022 and 2023, U.S. window shipments up approximately 6% in 2022, and U.S. residential semi-custom cabinet demand up approximately 4% in 2022. These are external industry estimates, not Quanex guidance.
- Cost and supply risks: Management highlighted raw-material inflation, supply-chain constraints, and timing lags in customer price adjustments, particularly for wood. Some inputs and customer arrangements are not fully covered by price adjusters, potentially limiting recovery of cost increases. The filing also identified labor availability, energy costs, foreign exchange, interest rates, housing and remodeling demand, and geopolitical uncertainty—including potential effects associated with Ukraine—as risks.
- COVID-19 and estimates: The company reported ongoing pandemic-related economic and supply-chain uncertainty and said changing conditions could require revisions to asset valuations, receivable reserves, or inventory estimates.
- Capital allocation and credit: In December 2021, the board authorized a share repurchase program of up to $75 million, with no expiration date. The revolving facility matures in October 2023; it has leverage and interest-coverage covenants and restricts certain transactions and dividends. The company amended the facility in December 2021, including provisions for the transition from LIBOR.
- Contingencies: Quanex is involved in claims alleging defects in a commercial sealant product sold in the 2000s. The company disputes the claims, has recorded no accrual, and says the outcome and timing are uncertain; it does not currently expect a material adverse effect on its overall financial condition, results, or cash flows. No environmental remediation matters were reported as currently active.
Most important facts for investors to verify
- Whether price increases continue to offset raw-material and labor inflation, and whether margin pressure—especially in EU Fenestration and Cabinet Components—eases.
- Whether inventory and other working-capital needs normalize after the quarter’s substantial operating cash outflow.
- Future credit-facility borrowings, covenant headroom, available liquidity, and the effect of variable interest rates; the filing estimates a 1 percentage-point rate change could affect annual pretax results by approximately $0.6 million.
- Whether the company proceeds with share repurchases under the $75 million authorization while debt and working-capital requirements remain elevated.
- Developments in the commercial sealant claims, including insurance coverage and any change to the company’s no-accrual assessment.